RBC Europe’s Lineage Cell Therapeutics LCTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q1 | – | Sell |
-5,700
| Closed | -$10K | – | 1216 |
|
|
2020
Q4 | $10K | Hold |
5,700
| – | – | ﹤0.01% | 877 |
|
|
2020
Q3 | $5.34K | Hold |
5,700
| – | – | ﹤0.01% | 899 |
|
|
2020
Q2 | $4.96K | Hold |
5,700
| – | – | ﹤0.01% | 869 |
|
|
2020
Q1 | $4.72K | Hold |
5,700
| – | – | ﹤0.01% | 835 |
|
|
2019
Q4 | $5.07K | Hold |
5,700
| – | – | ﹤0.01% | 900 |
|
|
2019
Q3 | $5.59K | Hold |
5,700
| – | – | ﹤0.01% | 885 |
|
|
2019
Q2 | $6.27K | Hold |
5,700
| – | – | ﹤0.01% | 885 |
|
|
2019
Q1 | $7.47K | Hold |
5,700
| – | – | ﹤0.01% | 876 |
|
|
2018
Q4 | $5.2K | Sell |
5,700
-815
| -13% | -$744 | ﹤0.01% | 919 |
|
|
2018
Q3 | $13.4K | Hold |
6,515
| – | – | ﹤0.01% | 771 |
|
|
2018
Q2 | $11.7K | Buy |
+6,515
| New | +$11.7K | ﹤0.01% | 815 |
|